Teleconsultation in Type 1 Diabetes Mellitus

Overview

The purpose of this study is to compare the effects on glycemic control of Teleconsultation versus standard visit in outpatient clinic for patients affected by type 1 diabetes mellitus.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 2018

Detailed Description

The growing incidence of diabetes and the need to contain health care costs empower the necessity to identify new models to cope with regular periodic follow up of patients affected by diabetes mellitus. Telemedicine offers an acknowledged instrument to provide clinical health care at a distance, increasing patient compliance and the achievement of therapeutical goals. This study wants to verify the feasibility and the efficacy of teleconsultation in patients with type 1 diabetes mellitus. In particular by a randomized controlled approach the effects on glycemic control of patients followed by teleconsultation or traditionally in standard visit in the outpatient clinic. The patients in the teleconsultation group will arrange their bookings on a website (http://www.telediabete-fid.it/) In this website they could also access to web educational courses (mainly nutrition, insulin management, glucose monitoring auto-control) or to nutritional and psychological counselling.

Interventions

  • Other: Teleconsultation
    • The patients in the consultation group arranged their bookings on a website, where they could also access to web educational courses or to nutritional and psychological counselling
  • Other: Standard
    • Group of patients followed in a traditional way

Arms, Groups and Cohorts

  • Experimental: Teleconsultation
    • Teleconsultation for patients affected by type 1 diabetes mellitus
  • Other: Control
    • Standard visit in outpatient clinic for the same type of patients

Clinical Trial Outcome Measures

Primary Measures

  • glycosylated hemoglobin HbA1c
    • Time Frame: 12th month
    • HbA1c is the main parameter representing the overall glycemic control. HbA1c can be assessed on three month bases but the value at 12 month is more representative of a sustained effect of this new approach

Secondary Measures

  • HbA1c glycosylated hemoglobin
    • Time Frame: 3rd to 6th to 9th month
    • changes of HbA1c glycosylated hemoglobin values
  • Patient satisfactory assessment by a questionnaire on their perception of advantages (diabetes management, comfort and convenience) and limits (technical problems, poor interaction with physicians) of the service
    • Time Frame: 12th month
    • A score of 1 (low) to 5 (High) will be used
  • Cost analysis by patient estimation through a questionnaire of the overall cost and time saved thanks to the service
    • Time Frame: 12th month
    • The average amount of cost and time saved will be calculated

Participating in This Clinical Trial

Inclusion Criteria

  • patients affected by type 1 diabetes mellitus, 5-50 years old under multi injection insulin therapy or under continuous subcutaneous insulin infusion – with a feasible web access Exclusion Criteria:

  • without a feasible web access – that need a periodic physical examination

Gender Eligibility: All

Minimum Age: 5 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Niguarda Hospital
  • Provider of Information About this Clinical Study
    • Sponsor

References

Bertuzzi F, Stefani I, Rivolta B, Pintaudi B, Meneghini E, Luzi L, Mazzone A. Teleconsultation in type 1 diabetes mellitus (TELEDIABE). Acta Diabetol. 2018 Feb;55(2):185-192. doi: 10.1007/s00592-017-1084-9. Epub 2017 Dec 5.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.